- Home
- OABI vs JMSB Comparison
OABI vs JMSB Comparison
Compare OABI & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OABI | JMSB |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.0M | 270.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OABI | JMSB |
|---|---|---|
| Price | $1.95 | $19.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.67 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 547.4K | 20.6K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | N/A | ★ 18.50 |
| EPS | N/A | ★ 1.40 |
| Revenue | $21,094,000.00 | ★ $59,274,000.00 |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | $66.19 | $12.72 |
| P/E Ratio | ★ N/A | $14.12 |
| Revenue Growth | 3.36 | ★ 11.69 |
| 52 Week Low | $1.22 | $13.81 |
| 52 Week High | $4.17 | $23.22 |
Technical Indicators
Market Signals| Indicator | OABI | JMSB |
|---|---|---|
| Relative Strength Index (RSI) | 66.48 | 54.01 |
| Support Level | $1.69 | $19.29 |
| Resistance Level | $1.64 | $20.22 |
| Average True Range (ATR) | 0.12 | 0.51 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 98.18 | 79.92 |
Price Performance
Historical ComparisonAbout OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.